|
Volumn 67, Issue 3, 2002, Pages 320-326
|
Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART
|
Author keywords
B lymphocytes; EBV; HIV; Immune reconstitution; PCR
|
Indexed keywords
ANTIRETROVIRUS AGENT;
FOSCARNET;
GANCICLOVIR;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
NUCLEOSIDE DERIVATIVE;
PROTEINASE INHIBITOR;
VIRUS ANTIGEN;
VIRUS DNA;
ARTICLE;
BODY BURDEN;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG RESPONSE;
EPSTEIN BARR VIRUS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NONHODGKIN LYMPHOMA;
SEROLOGY;
VIREMIA;
VIRUS LOAD;
NASA DISCIPLINE REGULATORY PHYSIOLOGY;
NON-NASA CENTER;
ADOLESCENT;
ADULT;
ANTIBODIES, VIRAL;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
DNA, VIRAL;
EPSTEIN-BARR VIRUS INFECTIONS;
HERPESVIRUS 4, HUMAN;
HIV ANTIBODIES;
HIV INFECTIONS;
HIV-1;
HUMANS;
MIDDLE AGED;
VIRAL LOAD;
HUMAN HERPESVIRUS 4;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0036271374
PISSN: 01466615
EISSN: None
Source Type: Journal
DOI: 10.1002/jmv.10080 Document Type: Article |
Times cited : (28)
|
References (20)
|